All News

Officials from the FDA have approved flortaucipir F18 (Tauvid, Eli Lilly) for intravenous injection as the first drug used to help image a distinctive characteristic of Alzheimer disease in the brain called tau pathology.

A new law approved in Minnesota this week expands pharmacists’ authority by allowing them to administer FDA-authorized COVID-19 or SARS-CoV-2 vaccines when they become available.

Artificial intelligence will inevitably play a major role in hub services, improving efficiency and speed to therapy.

Top news of the week from Pharmacy Times®.

What drug was the first antibiotic used by doctors?

FDA has granted Fast Track designation to Cardiff Oncology’s onvansertib, an oral and highly-selective Polo-like Kinase 1 (PLK1) inhibitor, for the second-line treatment of patients with KRAS-mutated metastatic colorectal cancer.

Pharma companies that shift their attention to what providers, payers, and patients are asking for will profit from the growing worldwide market on preventative care.

Today, we’re celebrating the work of Dan McCoy, PharmD, a pharmacist at CVS in Madison, Wisconsin.

The second annual States Forum on Pharmacist Birth Control Services recently was held by the Birth Control Pharmacist project in partnership with the National Alliance of State Pharmacy Associations (NASPA).

Despite triptan availability as a migraine-specific rescue, the global burden of migraine morbidity remains high.

By using certification as a start, health care professionals can carve their paths by honing soft skills, seeking additional clinical training, taking on more responsibilities, and developing advanced skills to continue moving upward.

The FDA approval of solifenacin succinate marks the first for the treatment of young pediatric patients with NDO.

New York Governor Andrew Cuomo announced last week that New York will launch a COVID-19 testing pilot program with a goal of conducting 7000 tests per week.

A study released today demonstrated that tocilizumab has been shown to significantly improve survival outcomes for patients with COVID-19.

Many patients are under the false assumption that there are no risks or potential drug interactions posed by taking OTC medications.

Artesunate for injection is on the World Health Organization Model List of Essential Medicines.

Pharmacists can leverage EHR to compare and contrast medication lists, link medications to patient problems, and evaluate effectiveness and adverse drug events.

Today, we’re celebrating Bailey Dodd, PharmD, and Macie Sobers, PharmD, both pharmacists at Walgreens in Birmingham, Alabama.

The therapy is approved for patients with squamous or non-squamous disease and regardless of programmed death-ligand 1 (PD-L1) expression.

Elizabeth Skoy, PharmD, and Amy Werremeyer, PharmD, BCPP, associate professors at the North Dakota State University School of Pharmacy, discuss what they feel is the value of the pharmacist.

Pharmacists are routinely putting others ahead of themselves and may not be sure how to find time for self-care.

The FDA recently announced its approval of a vaginal gel that acts as a method of contraception for women. It is the first non-hormonal, vaginal pH regulator contraceptive to be approved by the FDA.

The Nontraditional Pharmacist podcast presents a discussion about pharmacists practicing integrative medicine and touch on the business implications of integrative medicine in the future.

The work and expertise of a drug utilization pharmacist should be empowered and integrated earlier into a recall process.

Today, we’re thanking Dustin Linn, PharmD, RPh, BCCCP, and Trent Towne, PharmD, RPh, BCPS (AQID), for their work treating patients with COVID-19.

Migraines are a common condition, affecting about 38 million people in the United States and about 10% of people worldwide.

As we consider the implications of the COVID-19 pandemic and the release of remdesivir, ICER’s expedited evaluation raises some questions related to value-based pricing evaluations.

Although most children admitted to pediatric ICUs for COVID-19 had underlying conditions, children, teens, and young adults are at a greater risk for severe complications than researchers had previously believed.